Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
CoaStem KemOn is a biotech company engaged in the development of stem cell therapies and non-clinical CRO (Contract Research Organization) services. Its core business involves two main areas: the development of stem cell therapies for neurological diseases such as Lou Gehrig's disease (ALS), and the provision of non-clinical efficacy, toxicity, and safety evaluation services essential for the drug development process. The company operates within the biopharmaceutical development and research services industry.
코아스템켐온은 줄기세포 치료제 개발 및 비임상 CRO(Contract Research Organization) 사업을 영위하는 바이오 기업입니다. 주요 사업 영역은 루게릭병(ALS) 등 신경계 질환 치료를 위한 줄기세포 치료제 개발과 신약 개발 과정에 필요한 비임상 유효성, 독성, 안전성 평가 서비스 제공입니다. 이 회사는 바이오의약품 개발 및 연구 서비스 산업에 속합니다.
